Sable Bio
London, United Kingdom · Founded 2023 · $5.7M raised
- Headquarters
- London
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- sablebio.com
- Total Funding
- $5.7M
- Last Round
- $3.8M SeedFeb 2026
- Rounds
- 2
About
AI-powered drug safety platform that generates toxicology insights from unstructured trial data to accelerate drug discovery.
Summary
Sable Bio is a Biotech company based in London, United Kingdom, founded in 2023. It has raised $5.7M in total across 2 rounds, most recently a $3.8M Seed round in Feb 2026. Investors include Episode 1 Ventures, MMC Ventures and Seedcamp.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.